Clinical Trial Update: Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction

View source ↗

Summary

This is an observational trial update assessing patient satisfaction with Mixtard 30 NovoLet insulin in individuals with diabetes, with the study status reporte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Mixtard 30 NovoLet (insulin human premixed 30/70)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED